Commentary
Gene patents and the standard of care
Richard Gold, Timothy A. Caulfield and Peter N. Ray
CMAJ August 06, 2002 167 (3) 256-257;
Richard Gold
Dr. Gold is the BCE (Bell Canada Enterprise) Chair in E-Governance, Faculty of Law, McGill University, Montreal, Que. Mr. Caulfield is Research Director at the Health Law Institute and is Canada Research Chair in Health Law Policy and Associate Professor in the Faculty of Law and Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. Dr. Ray is Head of Molecular Genetics in the Department of Paediatric Laboratory Medicine, Hospital for Sick Children, and is Professor of Molecular and Medical Genetics, University of Toronto, Toronto, Ont.
Timothy A. Caulfield
Dr. Gold is the BCE (Bell Canada Enterprise) Chair in E-Governance, Faculty of Law, McGill University, Montreal, Que. Mr. Caulfield is Research Director at the Health Law Institute and is Canada Research Chair in Health Law Policy and Associate Professor in the Faculty of Law and Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. Dr. Ray is Head of Molecular Genetics in the Department of Paediatric Laboratory Medicine, Hospital for Sick Children, and is Professor of Molecular and Medical Genetics, University of Toronto, Toronto, Ont.
Peter N. Ray
Dr. Gold is the BCE (Bell Canada Enterprise) Chair in E-Governance, Faculty of Law, McGill University, Montreal, Que. Mr. Caulfield is Research Director at the Health Law Institute and is Canada Research Chair in Health Law Policy and Associate Professor in the Faculty of Law and Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. Dr. Ray is Head of Molecular Genetics in the Department of Paediatric Laboratory Medicine, Hospital for Sick Children, and is Professor of Molecular and Medical Genetics, University of Toronto, Toronto, Ont.
In this issue
Article tools
Gene patents and the standard of care
Richard Gold, Timothy A. Caulfield, Peter N. Ray
CMAJ Aug 2002, 167 (3) 256-257;